Robert G Phelps, MD

Clinical Focus

• Dermatomyositis
• Lupus
• Melanoma
• Scleroderma
• Skin Cancer

• Dermatomyositis
• Lupus
• Melanoma
• Scleroderma
• Skin Cancer

Research

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Article:174

Review Article:34

Comment/Debate:3

Letter:8

Recent Artifacts

• COVID-19 Vaccine-Induced Lichenoid Eruptions—Clinical and Histopathologic Spectrum in a Case Series of Fifteen Patients with Review of the Literature
• Subtlety of Granulomatous Mycosis Fungoides: A Retrospective Case Series Study and Proposal of Helpful Multimodal Diagnostic Approach With Literature Review
• Beyond JAAD July 2021: Articles of interest to dermatologists from the nondermatologic literature
• A case of neutrophilic superficial eccrine ductitis
• Beyond JAAD April 2021
• Unilateral verrucous psoriasis
• Beyond JAAD January 2021
• Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
• Oral lymphangiectasia and gastrointestinal Crohn disease
• Beyond JAAD October 2020: Articles of interest to dermatologists from the nondermatologic literature

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Phelps during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.